OR WAIT null SECS
May 07, 2024
Novel delivery technologies enhance brain penetration to target neurodegenerative diseases and glioblastomas.
ProPharm and PBL have introduced a fully automated, enclosed cell factory manufacturing device.
The two companies will combine their cell therapy platforms to develop convertibleCAR programs targeting solid tumors.
May 06, 2024
The request for more information was received weeks after an application to the FTC was refiled to approve the deal.
May 04, 2024
A new draft guidance issued by FDA covers human- and animal-derived materials used in the manufacture of advanced therapy medicinal products.
May 03, 2024
Cormica’s first US Acquisition is intended to support to organic growth of TPM laboratories.
Pharmaceutical company, Nanomerics, and several companies that work with the pharmaceutical industry have been recognized by King Charles III for business achievements.
The loan is intended to support Ennogen’s growth as it looks to international acquisitions.
Technological advances are helping advance biologics development and manufacturing and reduce bottlenecks.
May 02, 2024
Global product manager at Cytiva, Eric Corti, discusses the challenges with designing a new single-use mixing system that ensures leak-free fluid handling operations at INTERPHEX 2024.